Literature DB >> 798201

CI-719 in hyperlipoproteinaemia: interim data.

W F Bremner, J L Third, B Clark, C Corstorphine, T D Lawrie.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 798201      PMCID: PMC1864018     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  A relation between non-esterified fatty acids in plasma and the metabolism of glucose.

Authors:  V P DOLE
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

2.  Plasma free fatty acid and triglyceride transport kinetics in man.

Authors:  A H Kissebah; P W Adams; V Wynn
Journal:  Clin Sci Mol Med       Date:  1974-09

3.  The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism.

Authors:  P W Adams; A H Kissebah; P Harrigan; T Stokes; V Wynn
Journal:  Eur J Clin Invest       Date:  1974-06       Impact factor: 4.686

4.  Plasma lipoprotein lipase activity in primary type IV hyperlipoproteinaemia.

Authors:  J J Weir; D Cox; J H Moore; T D Lawrie
Journal:  Scott Med J       Date:  1972-06       Impact factor: 0.729

Review 5.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

6.  A mechanism by which high-density lipoproteins may slow the atherogenic process.

Authors:  T E Carew; T Koschinsky; S B Hayes; D Steinberg
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

7.  Familial and acquired type V hyperlipoproteinemia.

Authors:  R W Fallat; C J Glueck
Journal:  Atherosclerosis       Date:  1976 Jan-Feb       Impact factor: 5.162

  7 in total
  1 in total

Review 1.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.